The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000887370p
Ethics application status
Help: Ethics application status
Submitted, not yet approved
Date submitted
Help: Date submitted
29/06/2026
Date registered
Help: Date registered
17/07/2026
Date last updated
Help: Date last updated
4/09/2026
Date data sharing statement initially provided
Help: Data sharing statement date
17/07/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
Comparing standard and accelerated rehabilitation in adults aged 16–40 following arthroscopic shoulder stabilisation surgery: a pilot randomised controlled trial of shoulder function outcomes
Scientific title
Rehabilitation for Instability with Structured Elements (RISE) versus the American Society of Shoulder and Elbow Therapists (ASSET) standard protocol following arthroscopic Bankart repair in adults aged 16–40: a pilot randomised controlled trial of shoulder function and feasibility
Additional trial identifiers [1] 317342 0
Nil known
Universal Trial Number (UTN)
Trial acronym
Related trial records

Health condition
Health condition(s) studied:
Glenohumeral joint instability 342003 0
Postoperative rehabilitation following arthroscopic Bankart repair 342004 0
Condition category
Condition code
Musculoskeletal 338085 338085 0 0
Other muscular and skeletal disorders
Physical Medicine / Rehabilitation 338086 338086 0 0
Physiotherapy

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
The RISE (Rehabilitation for Instability with Structured Elements) protocol is a novel criterion-based rehabilitation program developed specifically for this trial. Rather than progressing at fixed time points, participants advance through four sequential stages (Early, Mid, Late, Return to Activity) by meeting specific clinical benchmarks across four concurrent elements: pain, range of motion, strength, and functional/psychological readiness. Meeting stage criteria advances exercise selection and load; the total number of sessions remains fixed at 10 regardless of progression rate.
Training is provided by the lead researcher: a 2-hour face-to-face session prior to trial commencement covering protocol rationale, stage progression criteria, and exercise selection, followed by monthly 1-hour face-to-face feedback and reflection sessions with treating physiotherapists throughout the trial period, which also serve as the ongoing supervision mechanism.
Delivered face-to-face and individually by registered physiotherapists with experience in post-surgical orthopaedic rehabilitation, independent of the research team and not involved in outcome assessment. Delivered at participating physiotherapy clinics (Sydney Orthopaedic Physiotherapy, St Leonards NSW; Penrith Physiotherapy Sports Centre, Penrith NSW).
10 sessions over 6 months post-operatively, each approximately 30–45 minutes (up to 60 minutes at stage-transition assessment sessions). Session frequency varies according to individual progression through protocol stages. Additional sessions are permitted if clinically indicated and are recorded. Exercise intensity progresses from low to high across the four stages, monitored using the Borg RPE scale, with a pain ceiling of =3/10 during and after loading. Example exercises include isometric rotator cuff and scapular setting exercises (Early stage); resisted band external/internal rotation and weight-bearing progressions (Mid stage); progressive loaded rotation, rows, and presses (Late stage); and sport-specific and plyometric loading (Return to Activity stage).
Adherence is monitored via physiotherapist-completed session attendance logs and treatment records. Protocol deviations are recorded.
Intervention code [1] 334567 0
Rehabilitation
Intervention code [2] 334568 0
Treatment: Other
Description of the comparator or control
The comparator is the ASSET (American Society of Shoulder and Elbow Therapists) consensus rehabilitation guideline - the current standard of care following arthroscopic Bankart repair. This is an active comparator, not a placebo or no-treatment control.
The guideline progresses through three phases defined by fixed post-operative time points: Phase 1 (protection, ~0-6 weeks) - sling immobilisation with protected passive range of motion; Phase 2 (early motion, ~6-12 weeks) - active range of motion introduced, strengthening begins; Phase 3 (strengthening and return to activity, from ~12 weeks) - progressive strengthening, with return-to-sport activities typically from ~16 weeks. Advancement requires both the time criterion and clinical milestones to be met.
Delivered by the same physiotherapists as the RISE arm, trained in the ASSET protocol prior to trial commencement (2-hour face-to-face session plus monthly supervision, identical structure to RISE training), independent of the research team. Delivered at the same participating clinics as the RISE arm. 10 sessions over 6 months post-operatively, following the time-based phase structure. Adherence monitored identically to the RISE arm via attendance logs, treatment records, and monthly supervision.
Control group
Active

Outcomes
Primary outcome [1] 345964 0
Shoulder function - Western Ontario Shoulder Instability (WOSI) Index (0-100%)
Timepoint [1] 345964 0
Timepoint: Pre-operatively, 6 weeks, 12 weeks, and 6 months post-operatively
Secondary outcome [1] 463960 0
Shoulder strength - external rotation limb symmetry index (LSI), supine 90/90 position
Timepoint [1] 463960 0
Pre-operatively, 12 weeks and 6 months post-operatively
Secondary outcome [2] 463961 0
Shoulder range of motion (ROM) - forward elevation (degrees)
Timepoint [2] 463961 0
Pre-operatively, 6 weeks, 12 weeks, and 6 months post-operatively
Secondary outcome [3] 463962 0
Pain - at rest
Timepoint [3] 463962 0
Pre-operatively, 6 weeks, 12 weeks, and 6 months post-operatively
Secondary outcome [4] 463963 0
Psychological readiness to return to sport
Timepoint [4] 463963 0
Baseline (pre-operative) and 6 months post-operatively
Secondary outcome [5] 463964 0
Participant satisfaction with rehabilitation
Timepoint [5] 463964 0
6 weeks, 12 weeks, and 6 months post-operatively
Secondary outcome [6] 463965 0
Return to activity/sport
Timepoint [6] 463965 0
4 months and 6 months post-operatively
Secondary outcome [7] 463966 0
Protocol adherence
Timepoint [7] 463966 0
Ongoing throughout the 6-month intervention period
Secondary outcome [8] 464711 0
Shoulder strength - external rotation limb symmetry index (LSI), supine pendant position
Timepoint [8] 464711 0
Pre-op, week 12, 6 months post-op
Secondary outcome [9] 464713 0
Shoulder strength internal rotation limb symmetry index (LSI), supine 90/90 position
Timepoint [9] 464713 0
Pre-op, week 12, 6 months post-op
Secondary outcome [10] 464714 0
Shoulder strength - internal rotation limb symmetry index (LSI), supine pendant position
Timepoint [10] 464714 0
Pre-op, week 12, 6 months post-op
Secondary outcome [11] 464717 0
Pain with activity
Timepoint [11] 464717 0
Pre-op, week 6, week 12, 6 months post-op
Secondary outcome [12] 464737 0
Time taken to return to activity/sport
Timepoint [12] 464737 0
6 months post-op
Secondary outcome [13] 464740 0
Shoulder range of motion (ROM) - abduction
Timepoint [13] 464740 0
Pre-op, week 6, week 12, 6 months post-op
Secondary outcome [14] 464743 0
Shoulder range of motion (ROM) - external rotation at 90deg abduction
Timepoint [14] 464743 0
Pre-op, week 12, 6 months post-op
Secondary outcome [15] 464744 0
Shoulder range of motion (ROM) - internal rotation at 90deg abduction
Timepoint [15] 464744 0
Pre-op, week 6, week 12, 6 months post-op

Eligibility
Key inclusion criteria
Aged 16–40 years
Scheduled for isolated arthroscopic Bankart repair for anterior shoulder instability
Diagnosis confirmed by orthopaedic surgeon based on clinical assessment and imaging
Sufficient English proficiency to provide informed consent and complete outcome measures
Able to attend scheduled physiotherapy and assessment sessions at a participating site
Minimum age
16 Years
Maximum age
40 Years
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
Beighton score greater than or equal to 5/9 (generalised hypermobility)
Glenoid bone loss greater than or equal to 15% on pre-operative imaging
Concurrent procedures performed at the time of Bankart repair that would require modification of the rehabilitation protocol (e.g. rotator cuff repair, SLAP repair, biceps tenodesis)
Prior ipsilateral shoulder stabilisation surgery
Significant health comorbidity precluding standard rehabilitation
Inability to comply with trial requirements (e.g. planned relocation, unavailability for follow-up)

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Centralised web-based randomisation system (Sealed Envelope). The allocation sequence is held by a member of the research team not otherwise involved in participant recruitment or care. Allocation is revealed only after the participant has been enrolled and consented, and is not accessible to recruiting staff or treating physiotherapists prior to that point.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Computer-generated permuted block randomisation with random block sizes, stratified by site, surgeon, age and sex. Generated using Sealed Envelope online randomisation software. Block sizes will not be disclosed to recruiting staff or treating physiotherapists.
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?


The people assessing the outcomes
The people analysing the results/data
Intervention assignment
Parallel
Other design features
Phase
Not Applicable
Type of endpoint/s
Safety/efficacy
Statistical methods / analysis

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
NSW

Funding & Sponsors
Funding source category [1] 321913 0
University
Name [1] 321913 0
RMIT
Country [1] 321913 0
Australia
Funding source category [2] 322272 0
Commercial sector/Industry
Name [2] 322272 0
Sydney Orthopaedic Physiotherapy (in-kind)
Country [2] 322272 0
Australia
Primary sponsor type
University
Name
RMIT University
Address
Country
Australia
Secondary sponsor category [1] 324774 0
None
Name [1] 324774 0
David O'Brian - Sydney Orthopaedic Physiotherapy
Address [1] 324774 0
Country [1] 324774 0
Australia

Ethics approval
Ethics application status
Submitted, not yet approved
Ethics committee name [1] 320447 0
Royal Melbourne Institute of Technology Human Research Ethics Committee
Ethics committee address [1] 320447 0
Ethics committee country [1] 320447 0
Australia
Date submitted for ethics approval [1] 320447 0
02/07/2026
Approval date [1] 320447 0
Ethics approval number [1] 320447 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 150518 0
Prof Evangelos Pappas
Address 150518 0
School of Health and Biomedical Sciences PO Box 71 Bundoora VIC 3083 Australia
Country 150518 0
Australia
Phone 150518 0
+61 3 9925 2000
Fax 150518 0
Email 150518 0
Contact person for public queries
Name 150519 0
David O'Brian
Address 150519 0
School of Health and Biomedical Sciences PO Box 71 Bundoora VIC 3083 Australia
Country 150519 0
Australia
Phone 150519 0
+61 2 9168 5992
Fax 150519 0
Email 150519 0
Contact person for scientific queries
Name 150520 0
David O'Brian
Address 150520 0
School of Health and Biomedical Sciences PO Box 71 Bundoora VIC 3083 Australia
Country 150520 0
Australia
Phone 150520 0
+61 2 9168 5992
Fax 150520 0
Email 150520 0

Data sharing statement
Will the study consider sharing individual participant data?
No
No IPD sharing reason/comment: Individual participant data will not be shared. De-identified aggregate data will be reported in publications and presentations. Given the small sample size of a pilot trial (n=30), sharing of individual participant data would carry a risk of re-identification even after de-identification, and no data sharing arrangement is in place with any third party.



What supporting documents are/will be available?

TypeCitationLinkEmailOther DetailsAttachment
Study protocol    Bankart trial protocol.docx
Informed consent form    Bankart PCF.docx


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.